Safely Buy Promacta ( Eltrombopag Olamine ) from Canada Prescriptions Plus.

Indications

Promacta is a platelet medication used to reduce the risk of bleeding in those with chronic immune thrombocytopenia and severe aplastic anemia by stimulating and increasing platelet counts.

Eltrombopag is a thrombopoietin (TBO) receptor agonist that stimulates megakaryocytes that lead to an increase in platelet production. This increase supports proper blood flow and allows Promacta to reduce the risk of bleeding in specific at-risk populations.

This medication has been found to be effective at reducing the risk of bleeding thanks to Promacta’s agonizing activity and stimulation of hematopoietic stem cells. By stimulating these cells, Promacta supports platelet production.

Uses and Dosage

The dose of Promacta that is prescribed will depend on the individual being treated. Follow your doctor’s instructions and read packaging labels carefully to ensure the best results during treatment.

• Swallow tablets whole
• Take on an empty stomach 1 hour before or 2 hours after a meal
• Take Promacta at least 2 hours before or 4 hours after eating calcium-rich foods
• Most adults take an initial dose of 50mg once daily
• Adults should not take more than 75mg a day
• Promacta is usually taken for 6 months
• The medication may take up to 4 weeks to prevent major bleeding events
• If you also take hepatitis medication, tell your doctor if you stop
• Store at room temperature away from moisture and heat
• Keep tablets in original container away from children and pets

Side Effects

Promacta may cause some side effects to develop while supporting the production of platelets in your blood. Speak with your doctor for more information related to any symptoms you may encounter when taking eltrombopag.

Common Promacta side effects:

• Nausea, diarrhea
• Fever
• Cough
• Headache, tiredness
• Anemia
• Abnormal bone marrow or liver function tests

Serious Side Effects

Some more serious side effects may occur when taking eltrombopag. Stop using Promacta and contact your doctor right away if you develop any of the following symptoms:

• Bruising or bleeding episodes during or after treatment
• Changes in vision, tunnel vision, eye pain, seeing halos around lights
• Pain or burning when urinating
• Low red blood cell count (pale skin, tiredness, feeling light-headed or short of breath, cold hands and feet)
• Liver problems (confusion, tiredness, upper stomach pain on the right side, swelling in the midsection area, dark urine, jaundice)

If your platelet counts become too high while taking Promacta, you could develop a blood clot. Seek immediate medical attention if you have any of the following:

• Signs of a stroke (sudden numbness or weakness, severe headache, slurred speech, vision or balance problems)
• Signs of a blood clot in the lung (chest pain, sudden cough or shortness of breath, dizziness, coughing blood)
• Signs of a blood clot deep in the body (pain, swelling, warmth in one leg)
• Signs of a blood clot in the stomach (severe stomach pain, vomiting, diarrhea)

Allergic Reactions

Do not take Promacta if you are allergic to eltrombopag. If you develop an allergic reaction, stop using this medication and call your doctor immediately.

Promacta allergy symptoms may include:

• Hives
• Difficulty breathing
• Swelling of you face, lips, tongue, or throat

Cautions

Avoid dairy products and those that contain calcium for at least four hours before taking Promacta.

If you have chronic hepatitis C, your risk of developing liver problems will increase if you take Promacta with ribavirin and interferon. Call your doctor right away if you notice any signs of liver problems. These symptoms include nausea, upper stomach pain, confusion, tiredness, loss of appetite, dark urine, clay-coloured stools, jaundice.

To ensure your safety in taking Promacta, tell your doctor if you have ever had any of the following:

• Blood clot
• Blood cancer
• Bleeding problems
• Cataracts
• Surgery to remove your spleen
• Liver disease

Ask your doctor before using an antacid while taking Promacta. These medications can make it harder for your body to absorb eltrombopag.

Some other drugs may interact with eltrombopag and cause adverse reactions. To ensure your safety, tell your doctor about all the medications you take, including over the counter medicines, but especially any of the following:

• Antacids containing calcium, magnesium, or aluminum
• Vitamin or mineral supplements containing aluminum, calcium, iron, magnesium, selenium, or zinc
• Medicine to prevent blood clots (alteplase, clopidogrel, dipyridamole, and others)
• Medication to lower cholesterol levels (atorvastatin, ezetimibe, fluvastatin, and others)

Your risk of bleeding may increase after you stop using Promacta. Be extra cautious for at least 4 weeks after stopping this medication to avoid cuts or injuries. You will need weekly blood tests at this time.

Do not use Promacta if you are pregnant because eltrombopag can cause harm to an unborn baby. Ensure that you use effective birth control while using Promacta and for at least a week after your last dose. Tell your doctor right away if you become pregnant.

Do not breastfeed while taking Promacta.

Form and Strength

This platelet medication is available in tablet form.

Promacta tablet strengths:

• 25mg
• 50mg

The 25mg Promacta tablets are available in quantities of 14 while the 50mg ones are available in quantities of 14 or 84.

FAQ

Is Promacta a steroid?

No, Promacta is not a steroid it uses eltrombopag, a thrombopoietin receptor agonist, to support the production and health of platelets in your body. This allows Promacta to prevent and reduce the risk of bleeding.

How long does it take for Promacta to work?

After your first dose of Promacta, it may take roughly two weeks to reach a significant increase in platelet counts. Eltrombopag needs time to work into your system and for its effects to become noticeable. This medication is often taken for 6 months to manage and prevent bleeding issues in those with chronic immune thrombocytopenia and severe aplastic anemia.

Resources:

1. https://pubmed.ncbi.nlm.nih.gov/31292909/
2. https://pubmed.ncbi.nlm.nih.gov/28423296/
3. https://www.drugs.com/promacta.html
4. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7714a0ed-34bb-46e6-a0a5-b363908b22c2